Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Novel variants in FOXI3 gene confirm its implication in Oculo-Auriculo-Vertebral spectrum

Abstract

Molecular bases of the clinically heterogenous Oculo-Auriculo-Vertebral Spectrum or Craniofacial Microsomia remain largely unknown. Although genetic diagnosis is established in less than 10% of the patients, variants in the FOXI3 gene are the most recurrent genetic cause. We studied a large family with 6 affected individuals on 4 generations showing an autosomal dominant transmission of Oculo-Auriculo-Vertebral Spectrum with incomplete penetrance. The genome sequencing strategy allowed the identification of a new likely pathogenic missense variant located within the Nuclear Localization Signal of FOXI3 and affecting its subcellular localization. Moreover, we described 3 additional rare FOXI3 variants identified in 3 other patients from a cohort of 251 patients with Oculo-Auriculo-Vertebral Spectrum. These variants were classified as Variants of Unknown Significance. In conclusion, this study confirms FOXI3 implication in the Oculo-Auriculo-Vertebral Spectrum and the importance of Nuclear Localization Signal integrity. Genotype-phenotype correlations and putative modifier haplotype are discussed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Families pedigree and functional in vitro tests of FOXI3 variants.

Similar content being viewed by others

Data availability

The data that support the findings of this study are available from the corresponding author upon request.

References

  1. Barisic I, Odak L, Loane M, Garne E, Wellesley D, Calzolari E, et al. Prevalence, prenatal diagnosis and clinical features of oculo-auriculo-vertebral spectrum: a registry-based study in Europe. Eur J Hum Genet. 2014;22:1026–33.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Tingaud-Sequeira A, Trimouille A, Sagardoy T, Lacombe D, Rooryck C. Oculo-auriculo-vertebral spectrum: new genes and literature review on a complex disease. J Med Genet. 2022;59:417–27.

  3. Tassano E, Jagannathan V, Drögemüller C, Leoni M, Hytönen MK, Severino M, et al. Congenital aural atresia associated with agenesis of internal carotid artery in a girl with a FOXI3 deletion. Am J Med Genet A. 2015;167:537–44. Mar 1

    Article  CAS  Google Scholar 

  4. Quiat D, Timberlake AT, Curran JJ, Cunningham ML, McDonough B, Artunduaga MA, et al. Damaging variants in FOXI3 cause microtia and craniofacial microsomia. Genet Med. 2023;25:143–50.

    Article  CAS  PubMed  Google Scholar 

  5. Mao K, Borel C, Ansar M, Jolly A, Makrythanasis P, Froehlich C, et al. FOXI3 pathogenic variants cause one form of craniofacial microsomia. Nat Commun. 2023;14:1–16.

  6. Berenguer M, Tingaud-Sequeira A, Colovati M, Melaragno MI, Bragagnolo S, Perez ABA, et al. A novel de novo mutation in MYT1, the unique OAVS gene identified so far. Eur J Hum Genet. 2017;25:1083–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Singh S, Jangid RK, Crowder A, Groves AK. Foxi3 transcription factor activity is mediated by a C-terminal transactivation domain and regulated by the protein phosphatase 2A (PP2A) complex. Sci Rep. 2018;1:17249.

Download references

Acknowledgements

The authors warmly thank the patients and their families. They thank the clinical geneticists for providing patients and Andrew Groves for providing plasmids for transactivation luciferase assay.

Funding

This project was supported by “La Fondation Maladies Rares” (project #12844-Genomics), “l’Académie Nationale de Médecine”and “l’Association Française d’ORL Pédiatrique”-Fondation Audika 2022.

Author information

Authors and Affiliations

Authors

Contributions

AS planned, performed experiments, analyzed data and co-wrote the manuscript; BL analyzed data; TS, ES, DL and AT clinically ascertained patients and provided samples; CR supervised, planned experiments, co-wrote and edited the manuscript.

Corresponding author

Correspondence to Angèle Sequeira.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

The local ethics committee (Comité de Protection des Personnes: DC2012/76) approved this study. Informed consent was obtained from the patients and/or their parents in the case of minors before genetic analysis was performed. Authorization for publication, including the publication of photographs, was obtained for patients 1.IV.4 and 2.II.3.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sequeira, A., Sagardoy, T., Bourgeade, L. et al. Novel variants in FOXI3 gene confirm its implication in Oculo-Auriculo-Vertebral spectrum. Eur J Hum Genet 33, 683–687 (2025). https://doi.org/10.1038/s41431-025-01837-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41431-025-01837-6

Search

Quick links